Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Raskob

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|May 3, 1990
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|May 9, 1994
Physician-guided treatment compared with a heparin protocol for deep vein thrombosisC G Elliott, S J Hiltunen, M Suchyta, et al.
Chest|December 1, 1985
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolismR D Hull, J Hirsh, C J Carter, et al.
Annals of Internal Medicine|January 10, 1998
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosisB G Birdwell, G E Raskob, T L Whitsett, et al.
Archives of Internal Medicine|February 10, 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspectiveR D Hull, G E Raskob, G F Pineo, et al.
Archives of Internal Medicine|January 27, 2000
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study GroupR D Hull, G E Raskob, R F Brant, et al.
JAMA|May 2, 1990
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacementR D Hull, G E Raskob, M Gent, et al.
Archives of Internal Medicine|August 1, 1992
Optimal therapeutic level of heparin therapy in patients with venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|February 10, 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspectiveR D Hull, G E Raskob, D Rosenbloom, et al.
The New England Journal of Medicine|October 30, 1986
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosisR D Hull, G E Raskob, J Hirsh, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|May 3, 1990
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|May 9, 1994
Physician-guided treatment compared with a heparin protocol for deep vein thrombosisC G Elliott, S J Hiltunen, M Suchyta, et al.
Chest|December 1, 1985
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolismR D Hull, J Hirsh, C J Carter, et al.
Annals of Internal Medicine|January 10, 1998
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosisB G Birdwell, G E Raskob, T L Whitsett, et al.
Archives of Internal Medicine|February 10, 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspectiveR D Hull, G E Raskob, G F Pineo, et al.
Archives of Internal Medicine|January 27, 2000
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study GroupR D Hull, G E Raskob, R F Brant, et al.
JAMA|May 2, 1990
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacementR D Hull, G E Raskob, M Gent, et al.
Archives of Internal Medicine|August 1, 1992
Optimal therapeutic level of heparin therapy in patients with venous thrombosisR D Hull, G E Raskob, D Rosenbloom, et al.
Archives of Internal Medicine|February 10, 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspectiveR D Hull, G E Raskob, D Rosenbloom, et al.
The New England Journal of Medicine|October 30, 1986
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosisR D Hull, G E Raskob, J Hirsh, et al.
Pageof 8